Tenth Annual Immunogenicity Bioassay Summit
-第10届免疫原性生物化验高峰会-
日期:2018年10月22-25日
地点:美国华盛顿特区,The Westin Alexandria

赞助商


会议日程


会议迈入第10年

由CHI主办的Immunogenicity and Bioassay Summit将于今年迈入第10年,产业界、学术界、监管机构主管将分析生物医药产业目前课题,并介绍新案例、新观点、新行动。本年度高峰会包含3组会议、1场座谈会及培训讲座,安排了深入探讨各项议题的丰富短期课程,透过团体讨论的互动,分享经验和想法并建立人脉。

2018年高峰会最终版议程将于近期公开。欢迎将本网站加入书签随时阅览。

2017年活动概要
  • 来自145多间企业超过250位人士莅临
  • 60多位专家演讲
  • 25件海报发表
  • 来自全球15个国家
  • 14间展示会参展商
>  2017年高峰会与会代表组织

与会者回响

“This conference provides very deep and broad scientific presentations, roundtable discussions, and excellent networking opportunities for scientists, managers/directors, CROs, vendors and consultants.”
- Senior Group Leader, Pfizer

“The Immunogenicity and Bioassay Summit covers up-to-date research and regulatory advances on all aspects of immunogenicity. It’s a very good meeting for experts and newcomers to the field.”
- Senior Director, Head, Bioanalytical and Biomarker Development, Research & Nonclinical Development, Shire

“Program and participants first class.”
- Associate Director, Novo Nordisk

“Great to get regulatory perspectives on challenges and expectations. The higher level strategic discussions were very informative.”
- Beth Arnold, Director, Biologics & Vaccine Bioanalytics, Merck

“Breakout interaction with FDA experts was very valuable.”
- Associate Director, Alexion Pharmaceuticals Inc.

2018年主要演讲者

Theresa Goletz, PhD
Global Head NBE DD
EMD Serono
little_thomasThomas Little, PhD
President and CEO, Bioassay Sciences
Thomas A. Little Consulting
Ira Pastan, MD
Co-Chief, Molecular Biology, National Cancer Institute
National Institutes of Health
Timothy Schofield
Senior Advisor, Technical Research & Development
GSK
Perceval Sondag
Senior Manager, Statistics
PharmaLex


Choose your language
Chinese
Japanese
Korean
English






免费电子邮件通知服务